These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model. Fernández-García M; Yañez RM; Sánchez-Domínguez R; Hernando-Rodriguez M; Peces-Barba M; Herrera G; O'Connor JE; Segovia JC; Bueren JA; Lamana ML Stem Cell Res Ther; 2015 Sep; 6(1):165. PubMed ID: 26345192 [TBL] [Abstract][Full Text] [Related]
3. A strategy for enhancing the engraftment of human hematopoietic stem cells in NOD/SCID mice. Lee SH; Kim DS; Lee MW; Noh YH; Jang IK; Kim DH; Yang HM; Kim SJ; Choi SJ; Oh W; Yang YS; Chueh HW; Son MH; Jung HL; Yoo KH; Sung KW; Koo HH Ann Hematol; 2013 Dec; 92(12):1595-602. PubMed ID: 23835655 [TBL] [Abstract][Full Text] [Related]
5. Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations. Wang J; Liao L; Wang S; Tan J Cytotherapy; 2013 Aug; 15(8):893-904. PubMed ID: 23751203 [TBL] [Abstract][Full Text] [Related]
6. Could mesenchymal stromal cells have a role in childhood autoimmune diseases? Pesmatzoglou M; Dimitriou H; Stiakaki E Immunol Invest; 2013; 42(7):639-56. PubMed ID: 24004061 [TBL] [Abstract][Full Text] [Related]
7. A Stro-1(+) human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system. Gonçalves R; Lobato da Silva C; Cabral JM; Zanjani ED; Almeida-Porada G Exp Hematol; 2006 Oct; 34(10):1353-9. PubMed ID: 16982328 [TBL] [Abstract][Full Text] [Related]
8. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Le Blanc K; Ringdén O Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285 [TBL] [Abstract][Full Text] [Related]
9. Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates. Masuda S; Ageyama N; Shibata H; Obara Y; Ikeda T; Takeuchi K; Ueda Y; Ozawa K; Hanazono Y Exp Hematol; 2009 Oct; 37(10):1250-1257.e1. PubMed ID: 19638293 [TBL] [Abstract][Full Text] [Related]
10. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [TBL] [Abstract][Full Text] [Related]
11. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis. Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726 [TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic applications of mesenchymal stromal cells. Larsen S; Lewis ID Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470 [TBL] [Abstract][Full Text] [Related]
15. Hematopoietic Stem Cells, Their Niche, and the Concept of Co-Culture Systems: A Critical Review. Vaidya A; Kale V J Stem Cells; 2015; 10(1):13-31. PubMed ID: 26665935 [TBL] [Abstract][Full Text] [Related]
16. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Maitra B; Szekely E; Gjini K; Laughlin MJ; Dennis J; Haynesworth SE; Koç ON Bone Marrow Transplant; 2004 Mar; 33(6):597-604. PubMed ID: 14716336 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts. de Oliveira GL; de Lima KW; Colombini AM; Pinheiro DG; Panepucci RA; Palma PV; Brum DG; Covas DT; Simões BP; de Oliveira MC; Donadi EA; Malmegrim KC Cell Transplant; 2015; 24(2):151-65. PubMed ID: 24256874 [TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Yi T; Song SU Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776 [TBL] [Abstract][Full Text] [Related]
19. Human adipose-derived stromal cells efficiently support hematopoiesis in vitro and in vivo: a key step for therapeutic studies. De Toni F; Poglio S; Youcef AB; Cousin B; Pflumio F; Bourin P; Casteilla L; Laharrague P Stem Cells Dev; 2011 Dec; 20(12):2127-38. PubMed ID: 21388235 [TBL] [Abstract][Full Text] [Related]
20. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination. Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]